Tweet
Defective Interfering Virus Protects Elderly Mice from Influenza
Paul D Scott, Bo Meng, Anthony C Marriott, Andrew J Easton and Nigel J Dimmock
For all author emails, please log on.
Virology Journal 2011, 8:212 doi:10.1186/1743-422X-8-212
Published: 9 May 2011
Abstract (provisional)
Background
We have identified and characterised a defective-interfering (DI) influenza A virus particles containing a highly deleted segment 1 RNA that has broad-spectrum antiviral activity. In young adult mice it exerts protection against several different subtypes of influenza A virus (defined here as homologous or genetically compatible protection) and against a paramyxovirus and an influenza B virus (heterologous or genetically unrelated protection). Homologous protection is mediated by replication competition between the deleted and full-length genomes, and heterologous protection occurs through stimulation of innate immunity, especially interferon type I.
Methods
A single dose of the protective DI virus was administered intranasally to elderly mice at -7, -1 and +1 days prior to intranasal challenge with influenza A virus.
Results
A single dose of the DI virus given 1 or 7 days protected elderly mice, reducing a severe, sometimes fatal disease to a subclinical or mild infection. In contrast, all members of control groups treated with inactivated DI virus before challenge became extremely ill and most died. Despite the subclinical/mild nature of their infection, protected mice developed solid immunity to a second infectious challenge.
Conclusions
The defective interfering virus is effective in preventing severe influenza A in elderly mice and may offer a new approach to protection of the human population.
Paul D Scott, Bo Meng, Anthony C Marriott, Andrew J Easton and Nigel J Dimmock
For all author emails, please log on.
Virology Journal 2011, 8:212 doi:10.1186/1743-422X-8-212
Published: 9 May 2011
Abstract (provisional)
Background
We have identified and characterised a defective-interfering (DI) influenza A virus particles containing a highly deleted segment 1 RNA that has broad-spectrum antiviral activity. In young adult mice it exerts protection against several different subtypes of influenza A virus (defined here as homologous or genetically compatible protection) and against a paramyxovirus and an influenza B virus (heterologous or genetically unrelated protection). Homologous protection is mediated by replication competition between the deleted and full-length genomes, and heterologous protection occurs through stimulation of innate immunity, especially interferon type I.
Methods
A single dose of the protective DI virus was administered intranasally to elderly mice at -7, -1 and +1 days prior to intranasal challenge with influenza A virus.
Results
A single dose of the DI virus given 1 or 7 days protected elderly mice, reducing a severe, sometimes fatal disease to a subclinical or mild infection. In contrast, all members of control groups treated with inactivated DI virus before challenge became extremely ill and most died. Despite the subclinical/mild nature of their infection, protected mice developed solid immunity to a second infectious challenge.
Conclusions
The defective interfering virus is effective in preventing severe influenza A in elderly mice and may offer a new approach to protection of the human population.
Comment